| Nome |
# |
|
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma, file e0d6c92c-9564-fcf8-e053-d805fe0aa794
|
277
|
|
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma, file e0d6c92c-be96-fcf8-e053-d805fe0aa794
|
256
|
|
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases, file e0d6c92c-94f7-fcf8-e053-d805fe0aa794
|
242
|
|
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans, file e0d6c92c-7962-fcf8-e053-d805fe0aa794
|
239
|
|
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)", file e0d6c92d-2b17-fcf8-e053-d805fe0aa794
|
217
|
|
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life, file e0d6c929-fdd5-fcf8-e053-d805fe0aa794
|
179
|
|
Inherited variants in genes somatically mutated in thyroid cancer, file e0d6c928-fb05-fcf8-e053-d805fe0aa794
|
147
|
|
Cabozantinib in progressive medullary thyroid cancer, file e0d6c92d-2274-fcf8-e053-d805fe0aa794
|
137
|
|
Role of Thyroglobulin, Neck Ultrasound, Thyroglobulin Antibodies Trend and Diagnostic Whole Body Scan in the Management of Differentiated Thyroid Cancer Patients with Persistent Thyroglobulin Antibodies, file e0d6c92a-aece-fcf8-e053-d805fe0aa794
|
131
|
|
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions, file e0d6c92c-2431-fcf8-e053-d805fe0aa794
|
118
|
|
null, file e0d6c928-21ad-fcf8-e053-d805fe0aa794
|
115
|
|
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk, file e0d6c926-f751-fcf8-e053-d805fe0aa794
|
113
|
|
Correction: Inherited variants in genes somatically mutated in thyroid cancer, file e0d6c92b-a3cc-fcf8-e053-d805fe0aa794
|
106
|
|
Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association, file e0d6c92c-f5bd-fcf8-e053-d805fe0aa794
|
103
|
|
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation, file e0d6c92c-7604-fcf8-e053-d805fe0aa794
|
102
|
|
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment., file e0d6c92b-0ecb-fcf8-e053-d805fe0aa794
|
98
|
|
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer, file e0d6c92c-f867-fcf8-e053-d805fe0aa794
|
96
|
|
Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid, file e0d6c92d-2b23-fcf8-e053-d805fe0aa794
|
96
|
|
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma, file e0d6c92c-ee1f-fcf8-e053-d805fe0aa794
|
59
|
|
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study, file e0d6c925-fc71-fcf8-e053-d805fe0aa794
|
53
|
|
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations, file e0d6c931-9531-fcf8-e053-d805fe0aa794
|
52
|
|
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology, file e0d6c92c-f272-fcf8-e053-d805fe0aa794
|
40
|
|
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system, file e0d6c931-4df3-fcf8-e053-d805fe0aa794
|
26
|
|
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities, file e0d6c931-2206-fcf8-e053-d805fe0aa794
|
18
|
|
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma, file e0d6c931-9ab1-fcf8-e053-d805fe0aa794
|
13
|
|
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade, file e0d6c931-4554-fcf8-e053-d805fe0aa794
|
11
|
|
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma, file e0d6c932-4860-fcf8-e053-d805fe0aa794
|
11
|
|
Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium, file e0d6c931-6f1e-fcf8-e053-d805fe0aa794
|
9
|
|
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases, file e0d6c92c-f6b9-fcf8-e053-d805fe0aa794
|
7
|
|
Obesity and the Risk of Papillary Thyroid Cancer: A Pooled Analysis of Three Case-Control Studies., file e0d6c926-43f3-fcf8-e053-d805fe0aa794
|
6
|
|
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk., file e0d6c926-4a84-fcf8-e053-d805fe0aa794
|
6
|
|
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations., file e0d6c926-4a8a-fcf8-e053-d805fe0aa794
|
6
|
|
Runs of homozygosity and inbreeding in thyroid cancer, file e0d6c92a-d269-fcf8-e053-d805fe0aa794
|
6
|
|
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer, file e0d6c92c-f876-fcf8-e053-d805fe0aa794
|
5
|
|
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form., file e0d6c926-1b79-fcf8-e053-d805fe0aa794
|
4
|
|
Surgical Management of Medullary thyroid carcinoma in pediatric age, file e0d6c928-1ace-fcf8-e053-d805fe0aa794
|
4
|
|
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24, file e0d6c926-4a89-fcf8-e053-d805fe0aa794
|
3
|
|
Genome-wide association study on differentiated thyroid cancer., file e0d6c926-4a8b-fcf8-e053-d805fe0aa794
|
3
|
|
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation, file e0d6c92b-a5b3-fcf8-e053-d805fe0aa794
|
3
|
|
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer, file e0d6c92d-2b19-fcf8-e053-d805fe0aa794
|
3
|
|
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates, file e0d6c931-d540-fcf8-e053-d805fe0aa794
|
3
|
|
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer, file e0d6c926-1e91-fcf8-e053-d805fe0aa794
|
2
|
|
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma, file e0d6c927-a263-fcf8-e053-d805fe0aa794
|
2
|
|
Use of low-dose radioiodine ablation for Gravesâ orbitopathy: results of a pilot, perspective study in a small series of patients, file e0d6c92c-bd90-fcf8-e053-d805fe0aa794
|
2
|
|
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment, file e0d6c92c-ee1d-fcf8-e053-d805fe0aa794
|
2
|
|
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study, file e0d6c92c-fdc9-fcf8-e053-d805fe0aa794
|
2
|
|
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology, file e0d6c92d-0ad0-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-0d88-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-29cc-fcf8-e053-d805fe0aa794
|
2
|
|
Calcitonin receptor expression in medullary thyroid carcinoma, file e0d6c92d-2b15-fcf8-e053-d805fe0aa794
|
2
|
|
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy, file e0d6c92e-74fc-fcf8-e053-d805fe0aa794
|
2
|
|
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I, file e0d6c92e-f6a4-fcf8-e053-d805fe0aa794
|
2
|
|
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion, file e0d6c92f-f79a-fcf8-e053-d805fe0aa794
|
2
|
|
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey, file e0d6c92f-f8f2-fcf8-e053-d805fe0aa794
|
2
|
|
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells, file e0d6c930-49db-fcf8-e053-d805fe0aa794
|
2
|
|
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience, file e0d6c930-a815-fcf8-e053-d805fe0aa794
|
2
|
|
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma, file e0d6c931-809d-fcf8-e053-d805fe0aa794
|
2
|
|
Molecular alterations in relation to histopathological characteristics in a large series of pediatric papillary thyroid carcinoma from a single institution, file e0d6c931-863b-fcf8-e053-d805fe0aa794
|
2
|
|
Ret mutated c-cells proliferate more rapidly than non-mutated neoplastic cells, file e0d6c931-cb54-fcf8-e053-d805fe0aa794
|
2
|
|
Higher RET gene expression levels do not represent an alternative RET activation mechanism in medullary thyroid carcinoma, file e0d6c931-cc40-fcf8-e053-d805fe0aa794
|
2
|
|
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?, file e0d6c931-d53e-fcf8-e053-d805fe0aa794
|
2
|
|
Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma, file 1acbe9e8-8b04-4d11-af16-d95e75ffb5eb
|
1
|
|
null, file e0d6c92c-d35b-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-e0f3-fcf8-e053-d805fe0aa794
|
1
|
|
Response to letter: "postoperative thyroglobulin and neck ultrasound in the risk restratification and decision to perform131i ablation", file e0d6c92c-ee23-fcf8-e053-d805fe0aa794
|
1
|
|
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer, file e0d6c92c-efe0-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-f1ad-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-f275-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-f28e-fcf8-e053-d805fe0aa794
|
1
|
|
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients, file e0d6c92d-09a1-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92d-2264-fcf8-e053-d805fe0aa794
|
1
|
|
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience, file e0d6c92d-2cd7-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92d-2f04-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92d-35c2-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92d-3b65-fcf8-e053-d805fe0aa794
|
1
|
|
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases, file e0d6c92f-1195-fcf8-e053-d805fe0aa794
|
1
|
|
Non thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?, file e0d6c92f-263b-fcf8-e053-d805fe0aa794
|
1
|
|
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH, file e0d6c92f-618d-fcf8-e053-d805fe0aa794
|
1
|
|
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer?, file e0d6c92f-7c24-fcf8-e053-d805fe0aa794
|
1
|
|
Efficacy and safety of vandetanib in progressive and symptomatic medullary thyroid Cancer: Post hoc analysis from the ZETA trial, file e0d6c930-4eba-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c931-41c7-fcf8-e053-d805fe0aa794
|
1
|
|
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center, file e0d6c931-b047-fcf8-e053-d805fe0aa794
|
1
|
|
Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs, file e0d6c931-cc42-fcf8-e053-d805fe0aa794
|
1
|
|
Bilateral testicular metastases of MTC in an adult male with MEN2A syndrome: case report and review of literature, file e0d6c931-fe0d-fcf8-e053-d805fe0aa794
|
1
|
|
A narrative review of genetic alterations in primary thyroid epithelial cancer, file e0d6c932-076f-fcf8-e053-d805fe0aa794
|
1
|
|
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine, file e0d6c932-3bff-fcf8-e053-d805fe0aa794
|
1
|
|
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses, file e0d6c932-44f0-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
3189 |